This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Dec;174(12):1747-1748.

doi: 10.7326/M21-4124. Epub 2021 Oct 26.

B-Cell Targeted Therapeutics in Systemic Lupus Erythematosus: From Paradox to Synergy?

Medha Barbhaiya¹, Katherine P Liao²

Affiliations

Affiliations

¹ Division of Rheumatology, Hospital for Special Surgery, and Departments of Medicine and Population Health Sciences, Weill Cornell Medicine, New York, New York.
² Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Department of Medicine and Biomedical Informatics, Harvard Medical School, and Rheumatology Section, Veterans Affairs Boston Healthcare System, Boston, Massachusetts.

PMID: 34698512
DOI: 10.7326/M21-4124

Editorial

B-Cell Targeted Therapeutics in Systemic Lupus Erythematosus: From Paradox to Synergy?

Medha Barbhaiya et al. Ann Intern Med. 2021 Dec.

. 2021 Dec;174(12):1747-1748.

doi: 10.7326/M21-4124. Epub 2021 Oct 26.

Authors

Medha Barbhaiya¹, Katherine P Liao²

Affiliations

¹ Division of Rheumatology, Hospital for Special Surgery, and Departments of Medicine and Population Health Sciences, Weill Cornell Medicine, New York, New York.
² Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Department of Medicine and Biomedical Informatics, Harvard Medical School, and Rheumatology Section, Veterans Affairs Boston Healthcare System, Boston, Massachusetts.

PMID: 34698512
DOI: 10.7326/M21-4124

No abstract available

PubMed Disclaimer

Comment on

Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial.
Shipa M, Embleton-Thirsk A, Parvaz M, Santos LR, Muller P, Chowdhury K, Isenberg DA, Doré CJ, Gordon C, Ehrenstein MR; BEAT-LUPUS Investigators. Shipa M, et al. Ann Intern Med. 2021 Dec;174(12):1647-1657. doi: 10.7326/M21-2078. Epub 2021 Oct 26. Ann Intern Med. 2021. PMID: 34698499 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information